Editorial Volume 21 Issue 7 - 2025

Exploring the Origins of Lymphopenia in Severe SARS COV-2: A Hypothesis Linking Heavy Metal Exposure and Viral Evolution

Mosab Nouraldein Mohammed Hamad*

Assistant Professor of Microbiology, Excellence Research Center, Elsheikh Abdallah Elbadri University, Berber, Sudan

*Corresponding Author: Mosab Nouraldein Mohammed Hamad, Assistant Professor of Microbiology, Excellence Research Center, Elsheikh Abdallah Elbadri University, Berber, Sudan.
Received: June 11, 2025; Published: July 01, 2025



Lymphopenia, a marked reduction in circulating lymphocytes, is frequently observed in patients with severe COVID-19 and is strongly associated with increased disease severity and poor clinical outcomes. This paper explores a novel hypothesis that environmental exposure to heavy metals-specifically lead (Pb) and cadmium (Cd)-may contribute both to the mutation of Influenza A virus into SARS-CoV-2 and to the pathogenesis of lymphopenia in COVID-19 patients. Lead is known to impair T lymphocyte function and promote a shift from Th1- to Th2-dominant immune responses, reducing antiviral efficacy. Similarly, cadmium exposure leads to decreased lymphocyte viability, increased apoptosis, and disrupted immune function. Both metals are associated with systemic inflammation and elevated neutrophil-to-lymphocyte ratios, further implicating them in SARS COV-2 severity. The hypothesis posits that co-exposure to Pb and Cd may not only trigger viral evolution but also intensify immune dysregulation, ultimately contributing to lymphopenia. Further research is needed to investigate this potential etiological pathway and its broader implications for immune health and pandemic readiness.

 Keywords: Lymphopenia; SARS-CoV-2; Lead (Pb); Cadmium (Cd); Heavy Metals; Immune Dysregulation; T Helper Cells; Th1/Th2 Imbalance; Immunotoxicity; Viral Mutation; Influenza A

  1. Fathi N and Rezaei N. “Lymphopenia in COVID‐19: Therapeutic opportunities”. Cell Biology International9 (2020): 1792-1797.
  2. Hamad MN. “COVID. 19: Man-made pandemic: Lead and Cadmium mutate Influenza virus and Produce: SARS COV-2”.
  3. Li S., et al. “The effect of lead on intracellular Ca2+ in mouse lymphocytes”. Toxicology In Vitro8 (2008): 1815-1819.
  4. Aleebrahim-Dehkordi E., et al. “T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses”. Transplant Immunology 70 (2022): 101495.
  5. Kratzer B., et al. “Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19”. Allergy9 (2024): 2482-2501.
  6. Mahallawi WH and Khabour OF. “Pandemic H1N1 influenza virus triggers a strong T helper cell response in human nasopharynx-associated lymphoid tissues”. Saudi Journal of Biological Sciences3 (2024): 103941.
  7. Ohsawa M and Kawai K. “Cytological shift in lymphocytes induced by cadmium in mice and rats”. Environmental Research1 (1981): 192-200.
  8. Poniedziałek B., et al. “Experimental immunology in vitro effect of cadmium on the function of human lymphocytes and neutrophils”. Central European Journal of Immunology2 (2012): 110-113.
  9. Chiu LC., et al. “Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study”. Environmental Health1 (2024): 29.
  10. Zhang H., et al. “Association between lead and cadmium co-exposure and systemic immune inflammation in residents living near a mining and smelting area in NW China”. Chemosphere 3 (2022): 132190.

Mosab Nouraldein Mohammed Hamad. “Exploring the Origins of Lymphopenia in Severe SARS COV-2: A Hypothesis Linking Heavy Metal Exposure and Viral Evolution”. EC Microbiology  21.7 (2025): 01-03.